Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control

BACKGROUND AND AIMS: Elevated plasma asymmetric dimethylarginine (ADMA) levels have been observed in patients with insulin resistance and diabetes, and have been reported to predict adverse cardiovascular events in type 2 diabetic patients. However, the relationship between ADMA and glycemic control...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chiao-Po, Hsu, Pai-Feng, Chung, Ming-Yi, Lin, Shing-Jong, Lu, Tse-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262144/
https://www.ncbi.nlm.nih.gov/pubmed/25467091
http://dx.doi.org/10.1186/s12933-014-0156-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262144/
https://www.ncbi.nlm.nih.gov/pubmed/25467091
http://dx.doi.org/10.1186/s12933-014-0156-1

Ejemplares similares